Driven by OHSU research, FDA approves new drug to prevent hearing loss in children with cancer
January 17, 2023
Treatment with sodium thiosulfate will improve health outcomes and quality of life for pediatric cancer patients.
Increasing cancer awareness, screening in underserved communities
January 12, 2023
OHSU funds projects to provide culturally relevant resources, education, workshops for people across Oregon.
OHSU 2022 accomplishments: The year in review
December 28, 2022
As the year 2022 draws to a close, it’s worth pausing to reflect on a historic era.
Lisa Coussens, Ph.D.
December 21, 2022
Lisa Coussens, Ph.D., Associate Director for Basic Research, OHSU Knight Cancer Institute; Chair, Department of Cell, Developmental and Cancer Biology, OHSU School of Medicine. (OHSU)
OHSU Knight Cancer Institute tapped for participation in a national consortium to accelerate cancer drug discovery
December 20, 2022
As the only center in the Pacific Northwest, OHSU will collaborate with other selected centers to address unmet needs in cancer therapy.
Nanotechnology may better identify, treat ectopic pregnancy
November 21, 2022
Ectopic pregnancies are a leading cause in pregnancy-related deaths.
Doernbecher Freestyle XVIII returns in person for the big reveal
October 31, 2022
Six young patient-designers revealed their personally designed Nike and Air Jordan collections; event benefits OHSU Doernbecher Children’s Hospital.
University of Oregon football helmet auction raises more than $66,000 for breast cancer research at OHSU
October 26, 2022
OHSU Knight Cancer Institute director, employees share their appreciation in a thank-you video.
Gun violence prevention is focus of final Marquam Talks lecture series
October 25, 2022
OHSU researcher Kathleen Carlson will discuss gun violence as a public health issue in free public event.
Study confirms the unique danger of postpartum breast cancers
October 14, 2022
A postpartum cancer diagnosis can move women who appear to have good prognosis into a high-risk category.
